Duke University engineers created an oral method to deliver GLP-1 drugs without fasting. The approach protects peptide medications from stomach acid, keeping them effective.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Oral GLP-1s without fasting or reduced efficacy: Delivery approach protects peptide-based drugs from stomach acid
Acidic Buffer Nanoparticle System Delivery method
GLP-1 Peptides Drug type
Insulin, IBS, HIV, Osteoporosis Treatments Applies to